Keywords: enthusiasm, amgen, obesity, drug, palls, platform, technology

Enthusiasm For Amgen Obesity Drug Palls

Article | 12 February 1996

Print This

Amgen's platform technology in its anti-obesity program, the ob gene and its peptide product leptin, may not be the potential ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in